Setting Up Biometrics in India
Extending a global function, or building one from zero. A practitioner’s guide for CROs and pharma and biotech sponsors: why India, the four layers in build order, two case tracks, where the money goes in year one, inspection readiness, and a readiness checklist for each case. By Sagar Kalantre, Founder Director & CEO, Praveg.
Biometrics functions in India rarely fail on talent. They fail on sequence and on governance.
India has the talent. What decides whether a Biometrics function succeeds is the order in which it is built, and the decision rights it is given once it exists. This paper is written for two readers who share a destination and start from different places.
Case A is the established CRO or pharma or biotech sponsor headquartered outside India that already runs Clinical Data Management, Statistical Programming and Biostatistics and wants a second site in India that does not dilute the first. Case B is the India-based CRO or sponsor that currently outsources Biometrics and wants to internalise it, building the function for the first time.
You are not buying a team. You are building a quality system that happens to employ people.The shared argument, Section 1
The function has four layers, built in order: governance and scope, then process and quality system, then systems and validation, and only then people and volume. Case A inherits the first three layers from headquarters and must transfer them without losing the evidence behind them; Case B must build all four. Built in the right order and given the decision rights that go with ownership, the function reaches its first live study or independent operation in seven to twelve months, passes its first sponsor audit on the evidence it built in from day one, crosses cost in year two, and keeps the people who built it. Built out of order, or governed as a place to put work, it spends its second year repairing its first.
The paper draws on Praveg’s own experience setting up Biometrics functions for CROs and establishing teams in India for global organisations, the author’s twenty years inside sponsor, CRO and IT services organisations, and published regulatory and market sources cited throughout. It is deliberately frank about cost, dual running and sequence.
The four layers, in the order they must be built.
Praveg’s approach to any organisational build starts from a simple principle: diagnose before you act, then design, implement and govern. Applied to a Biometrics build, that sequencing almost always lands on the same conclusion: four layers, each of which only works if the one beneath it is in place. The timelines are indicative; the order is not negotiable.
Governance and scope
Service scope (CDM only, CDM plus programming, or full Biometrics), phases and study types, full-service or data-only, decision rights, a named executive sponsor and a separate budget owner, the target operating model.
When skipped: Systems bought for the wrong workload; an SOP set either bloated or incomplete; the wrong hiring profile.Process and quality system
A minimum viable SOP architecture aligned to GCDMP and written against ICH E6(R3), templates for the DMP, SAP, edit checks and reconciliation plans, QMS, training and qualification, change control, vendor qualification.
When skipped: Each study invents its own process; audits find version-control and training gaps first; the sixty-SOP trap.Systems and validation
EDC, statistical environment, CDISC tooling and document management chosen on validation burden and sponsor compatibility, not feature count; a named validation owner with a budget line; a Part 11 posture; revalidation triggers.
When skipped: People hired into an unvalidated environment; the first sponsor audit finds the system, not the data.People and organisation
The first three hires set the culture: a Biometrics lead, a senior statistical programmer and a data management lead, all of whom have audited and been audited. Volume hires after the first study is configured. Retention designed for the six-to-ten-year band.
When skipped: Culture set by whoever arrived first; attrition in year two; knowledge concentrated in one person.The sequencing consequence most often ignored: do not hire the delivery team until the environment is validated and the first study configuration has been dry-run. Teams of six sitting idle for weeks because EDC validation slipped are billable, bored, and taking calls from recruiters.
Two case tracks, one set of foundations
Extending an existing Biometrics function to India
The SOPs exist, the systems are validated and the quality culture has an audit history. The question is harder than building from zero: how do you replicate a function you already run well, in a country where you have never operated, without turning it into a cheaper and worse copy of itself?
- Three routes compared: own build (9 to 12 months), partner-led or build-operate-transfer (5 to 8 months, can extend to two years), acquisition (fastest on paper, slowest to integrate)
- What transfers from headquarters as-is, and what does not: global SOPs as controlling documents with local annexes, a site-level validation evidence plan for the shared system instance
- The governance model: an autonomous unit with shared standards, measured on outcomes rather than utilisation, with a dated transition from hub-and-spoke
- The logistics headquarters underestimates, hiring in India from outside India, and the five mistakes that are expensive to undo
- Year-one cost shares, including dual running and HQ time at 10 to 20%, the line most plans omit
- A composite case: a mid-sized European CRO whose “India delivery centre” became its second Biometrics hub
Standing up Biometrics from zero
For the India-based CRO or sponsor that currently outsources data management, programming and statistics. The order in which the four layers are built decides whether year two is spent growing or repairing.
- The scope decision in detail: CDM only, CDM plus programming, or full Biometrics; phase and study type; full-service or data-only
- Why own the function at all: margin, sponsor confidence, control of the critical path, and the direction of ICH E6(R3)
- When owning it is wrong, and when a hybrid model (small in-house core, vendor overflow) is the better answer
- Year-one cost shares: people 45 to 55%, systems and validation 25 to 35%, process and training 10 to 15%; three hidden budget lines
- Break-even against outsourcing: eight to twelve people typically overtake outsourced cost at five to seven concurrent studies, usually in year two
- Five mistakes that are expensive to undo, starting with buying the EDC before deciding the service scope
Inspection readiness from day one
A new Biometrics function, or a new India site of an existing one, will be audited by sponsors well before any regulator sees it. Build as if the first sponsor audit were in month seven, because it often is. The areas a sponsor quality team examines first in a young function:
- SOP version control and the training records that prove staff were trained on the current version
- System validation evidence and change control, including revalidation after protocol amendments
- Role coverage: vacant or interim critical roles, and whether a deputy exists
- Study-level artefacts (DMP, edit-check specification, lock checklist), each in exactly one current version
- Query and data-review metrics tracked by site, not only by study
- Data-handling procedures written against the DPDP Rules, 2025 and, for EU sponsors, GDPR
Two readiness checklists
Yes-or-no questions for each case, grouped by theme. A sample of each:
| Case A, for HQ leadership | Case B, for the first-time builder |
|---|---|
| Is there a named executive sponsor and a separate budget owner for the India site? | Is the service scope (services, phases, full-service or data-only) written down and signed off? |
| Are global SOPs adopted as controlling documents with local annexes, rather than a forked set? | Is there a minimum viable SOP set sized for the function, aligned to GCDMP and ICH E6(R3)? |
| Is the site measured on outcomes rather than utilisation? | Is validation owned by a named person with a budget line? |
| Does the business case show the dual-running period and a realistic crossover in year two? | Are the first three hires defined, with audit experience as a requirement? |
The full checklists (15 and 14 questions) are in the PDF. Praveg offers them as a self-assessment; the fuller diagnostic behind its set-up engagements is the Praveg OPTIC Maturity Model™.
The full paper, in your browser
Field vignettes and composite cases are drawn from real engagements and have been anonymised, compressed and in places composited. Indicative timelines, cost shares, break-even and crossover figures are Praveg planning ranges and should be validated against a specific organisation’s scope and plan before use. Nothing in the paper is legal advice.
Building, or extending? Start with the scope conversation.
Praveg has set up Biometrics functions for CROs and established teams in India for global organisations. The first intervention is almost always on governance and scope, not logistics, and it is the cheapest point at which to get the sequence right.
- Scope, governance and decision-rights design; executive sponsor and budget-owner model
- Minimum viable SOP set aligned to GCDMP and ICH E6(R3), with local annexes for an India site
- EDC and statistical environment selection on validation burden and sponsor compatibility; validation ownership
- First-three-hires profiles, qualification-before-assignment and retention design
- Inspection readiness before the first sponsor audit; DPDP Rules 2025 and GDPR data-handling procedures
- Break-even modelled on your actual pipeline
Setting up Biometrics in India, answered
Who is this white paper for?
Two readers. Case A: established CROs and pharma or biotech sponsors headquartered outside India that want a second Biometrics site in India without diluting the first. Case B: India-based CROs and sponsors that currently outsource Clinical Data Management, Statistical Programming and Biostatistics and want to internalise them.
What are the four layers of a Biometrics function?
Governance and scope; process and quality system; systems and validation; and people and organisation, built in that order. Case B builds all four. Case A inherits the first three from headquarters and must transfer them without losing the evidence behind them. Skipping a layer produces a predictable failure: systems bought for the wrong workload, each study inventing its own process, people hired into an unvalidated environment, or knowledge concentrated in one person.
How long does it take to set up Biometrics in India?
Indicatively seven to twelve months to a first live study (Case B) or independent operation (Case A). Own build typically reaches a first live study in nine to twelve months; a partner-led or build-operate-transfer route in five to eight months but can extend to two years; acquisition is fastest on paper but integration can take longer than a build. Timelines are Praveg planning ranges, and the order of the layers is not negotiable.
What does the first year cost, and when does it break even?
For a first-time builder, roughly 45 to 55% of year-one cost is people including recruitment and first-year attrition replacement, 25 to 35% systems and validation, 10 to 15% process, quality system and training, and 5 to 10% infrastructure. For an extension from headquarters, dual running and HQ time take 10 to 20%, the line most plans omit. An in-house CDM-plus-programming function of eight to twelve people typically overtakes outsourced cost once it sustains five to seven concurrent studies, usually in the second year. Below three or four concurrent studies a hybrid model is usually the better answer.
When is owning Biometrics the wrong decision?
When study volume cannot keep a minimum viable team busy, when the therapeutic focus is too narrow to justify fixed cost with an uncertain pipeline, or when no one at executive level will own the build. For Case A, a second site adds risk rather than capacity when the HQ function is itself under strain, when the business case is cost alone, or when no one from headquarters will spend meaningful time in India in the first year.
What will a sponsor audit look at first in a new function?
SOP version control and the training records that prove staff were trained on the current version; system validation evidence and change control, including revalidation after protocol amendments; vacant or interim critical roles and whether a deputy exists; study-level artefacts in exactly one current version; and query and data-review metrics tracked by site, not only by study. Data-handling procedures written against India's DPDP Rules 2025 and, where EU sponsors are involved, GDPR, are now part of inspection readiness.
Does Praveg help with the set-up itself?
Yes. Praveg has set up Biometrics functions for CROs and established teams in India for global organisations, and supports both tracks: scope and governance design, the minimum viable SOP set aligned to GCDMP and ICH E6(R3), system selection and validation ownership, the first three hires, and inspection readiness before the first sponsor audit. The paper's checklists are a self-assessment; the fuller diagnostic behind Praveg's engagements is the Praveg OPTIC Maturity Model.
Let’s get the sequence right.
A discovery conversation about your case, your scope and your timeline. No obligation.